Social Capital Hedosophia Holdings Corp. II (IPOB.U), announced the pricing of their upsized $360 million SPAC IPO this evening and the units are expected to begin trading tomorrow, Tuesday, April 28th, under the symbol NYSE: IPOB.U.
Social Capital Hedosophia II’s pricing follows last week’s IPO of Social Capital Hedosophia III (IPOC.U), which went public on Tuesday, April 24th. Both IPOB.U and IPOC.U are the follow-up SPACs to the original Social Capital Hedosophia Holdings Corp, which combined with Virgin Galactic (SPCE), in October 2019.
Social Capital Hedosophia II (IPOB.U), will be focusing on technology companies located inside the U.S. and will once again be led by the team of Chamath Palihapitiya, as CEO and Chairman, and Ian Osborne, as President and Director.
Total SPAC deal count for 2020 year-to-date is now 17 with $5.558 billion in gross proceeds raised. The offering is anticipated to close on Thursday, April 30, 2020.
Credit Suisse is acting as sole book-running manager of the offering. Skadden, Arps, Slate, Meagher & Flom LLP and Shearman & Sterling LLP were Issuer’s Counsel and Underwriter’s Counsel, respectively. Marcum LLP acted as auditor.
Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...
At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...